title: Effect of ruboxistaurin on albuminuria and estimated GFR in people with diabetic peripheral neuropathy: results from a randomized trial.
authors.affiliation: Providence Health Care & University of Washington School of Medicine, Spokane, Washington.
authors.forename: Katherine R
authors.initials: KR
authors.lastname: Tuttle
authors.affiliation: Washington University, St Louis, Missouri.
authors.forename: Janet B
authors.initials: JB
authors.lastname: McGill
authors.affiliation: Eli Lilly & Co, Indianapolis, Indiana.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Bastyr
authors.affiliation: Eli Lilly & Co, Indianapolis, Indiana.
authors.forename: Keri Kles
authors.initials: KK
authors.lastname: Poi
authors.affiliation: Inventiv Health Clinical, La Jolla, California.
authors.forename: Nazila
authors.initials: N
authors.lastname: Shahri
authors.affiliation: Eli Lilly & Co, Indianapolis, Indiana. Electronic address: anderson_pamela_w@lilly.com.
authors.forename: Pamela W
authors.initials: PW
authors.lastname: Anderson
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D003404:Creatinine / Q000652:urine; D003929:Diabetic Neuropathies / Q000150:complications*; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use*; D008297:Male; D008301:Maleimides / Q000494:pharmacology* / Q000627:therapeutic use*; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000150:complications; D064546:Protein Kinase C beta / Q000037:antagonists & inhibitors / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; C099154:ruboxistaurin; D003404:Creatinine; D064546:Protein Kinase C beta